147 related articles for article (PubMed ID: 23606431)
1. Multimodal imaging of tumor response to sorafenib combined with radiation therapy: comparison between diffusion-weighted MRI, choline spectroscopy and 18F-FLT PET imaging.
Karroum O; Mignion L; Kengen J; Karmani L; Levêque P; Danhier P; Magat J; Bol A; Labar D; Grégoire V; Bouzin C; Feron O; Gallez B; Jordan BF
Contrast Media Mol Imaging; 2013; 8(3):274-80. PubMed ID: 23606431
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism.
Mignion L; Danhier P; Magat J; Porporato PE; Masquelier J; Gregoire V; Muccioli GG; Sonveaux P; Gallez B; Jordan BF
Int J Cancer; 2016 Apr; 138(8):2043-9. PubMed ID: 26595604
[TBL] [Abstract][Full Text] [Related]
3. Multimodal assessment of early tumor response to chemotherapy: comparison between diffusion-weighted MRI, 1H-MR spectroscopy of choline and USPIO particles targeted at cell death.
Radermacher KA; Magat J; Bouzin C; Laurent S; Dresselaers T; Himmelreich U; Boutry S; Mahieu I; Vander Elst L; Feron O; Muller RN; Jordan BF; Gallez B
NMR Biomed; 2012 Apr; 25(4):514-22. PubMed ID: 21874657
[TBL] [Abstract][Full Text] [Related]
4. FLT-PET may not be a reliable indicator of therapeutic response in p53-null malignancy.
Katz SI; Zhou L; Ferrara TA; Wang W; Mayes PA; Smith CD; El-Deiry WS
Int J Oncol; 2011 Jul; 39(1):91-100. PubMed ID: 21537838
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antiangiogenic and antiproliferative effects of sorafenib by sequential histology and intravoxel incoherent motion diffusion-weighted imaging in an orthotopic hepatocellular carcinoma xenograft model.
Yang SH; Lin J; Lu F; Han ZH; Fu CX; Lv P; Liu H; Gao DM
J Magn Reson Imaging; 2017 Jan; 45(1):270-280. PubMed ID: 27299302
[TBL] [Abstract][Full Text] [Related]
6. Quantitative correlation at the molecular level of tumor response to docetaxel by multimodal diffusion-weighted magnetic resonance imaging and [¹⁸F]FDG/[¹⁸F]FLT positron emission tomography.
Honndorf VS; Schmidt H; Wehrl HF; Wiehr S; Ehrlichmann W; Quintanilla-Martinez L; Barjat H; Ricketts SA; Pichler BJ
Mol Imaging; 2014; 13():. PubMed ID: 25430886
[TBL] [Abstract][Full Text] [Related]
7. Voxel-Based Analysis of the Relation of 3'-Deoxy-3'-[
Schelhaas S; Frohwein LJ; Wachsmuth L; Hermann S; Faber C; Schäfers KP; Jacobs AH
Mol Imaging Biol; 2022 Jun; 24(3):359-364. PubMed ID: 34755247
[TBL] [Abstract][Full Text] [Related]
8. Assessment of early therapeutic response to sorafenib in renal cell carcinoma xenografts by dynamic contrast-enhanced and diffusion-weighted MR imaging.
Jeon TY; Kim CK; Kim JH; Im GH; Park BK; Lee JH
Br J Radiol; 2015 Sep; 88(1053):20150163. PubMed ID: 26133222
[TBL] [Abstract][Full Text] [Related]
9. The Synergistic Effect of Selumetinib/Docetaxel Combination Therapy Monitored by [(18)F]FDG/[(18)F]FLT PET and Diffusion-Weighted Magnetic Resonance Imaging in a Colorectal Tumor Xenograft Model.
Honndorf VS; Schmidt H; Wiehr S; Wehrl HF; Quintanilla-Martinez L; Stahlschmidt A; Barjat H; Emmas SA; Pichler BJ
Mol Imaging Biol; 2016 Apr; 18(2):249-57. PubMed ID: 26276154
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric MR diffusion-weighted imaging for monitoring the ultra-early treatment effect of sorafenib in human hepatocellular carcinoma xenografts.
Chen X; Ma Z; Huang Y; He L; Liang C; Shi C; Zhang Z; Liang C; Liu Z
J Magn Reson Imaging; 2017 Jul; 46(1):248-256. PubMed ID: 27783444
[TBL] [Abstract][Full Text] [Related]
11. DW-MRI and (18) F-FLT PET for early assessment of response to radiation therapy associated with hypoxia-driven interventions. Preclinical studies using manipulation of oxygenation and/or dose escalation.
Tran LB; Bol A; Labar D; Karroum O; Mignion L; Bol V; Jordan BF; Grégoire V; Gallez B
Contrast Media Mol Imaging; 2016; 11(2):115-21. PubMed ID: 27041693
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3'-Deoxy-3'-[18F]Fluorothymidine in Preclinical Models of Lung Cancer.
Schelhaas S; Held A; Wachsmuth L; Hermann S; Honess DJ; Heinzmann K; Smith DM; Griffiths JR; Faber C; Jacobs AH
Cancer Res; 2016 Dec; 76(24):7096-7105. PubMed ID: 27784748
[TBL] [Abstract][Full Text] [Related]
13. 18F-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients.
Hoeben BA; Troost EG; Bussink J; van Herpen CM; Oyen WJ; Kaanders JH
Nuklearmedizin; 2014; 53(2):60-6. PubMed ID: 24468965
[TBL] [Abstract][Full Text] [Related]
14. Response Monitoring with [
Heskamp S; Heijmen L; Gerrits D; Molkenboer-Kuenen JDM; Ter Voert EGW; Heinzmann K; Honess DJ; Smith DM; Griffiths JR; Doblas S; Sinkus R; Laverman P; Oyen WJG; Heerschap A; Boerman OC
Mol Imaging Biol; 2017 Aug; 19(4):540-549. PubMed ID: 27798786
[TBL] [Abstract][Full Text] [Related]
15. Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.
Chang JH; Lim Joon D; Davis ID; Lee ST; Hiew CY; Esler S; Gong SJ; Wada M; Clouston D; O'Sullivan R; Goh YP; Bolton D; Scott AM; Khoo V
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):438-45. PubMed ID: 25864171
[TBL] [Abstract][Full Text] [Related]
16. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism.
Tseng JC; Narayanan N; Ho G; Groves K; Delaney J; Bao B; Zhang J; Morin J; Kossodo S; Rajopadhye M; Peterson JD
PLoS One; 2017; 12(8):e0182689. PubMed ID: 28792505
[TBL] [Abstract][Full Text] [Related]
19. Early response of hepatic malignancies to locoregional therapy-value of diffusion-weighted magnetic resonance imaging and proton magnetic resonance spectroscopy.
Bonekamp S; Shen J; Salibi N; Lai HC; Geschwind J; Kamel IR
J Comput Assist Tomogr; 2011; 35(2):167-73. PubMed ID: 21412085
[TBL] [Abstract][Full Text] [Related]
20. Imaging proliferation in human leukemia-tumor bearing mice with (18)F-FLT: Comparison with (18)F-FDG PET.
Lu L; Jiang L; Guan H; Gao Y; Lu H
Hell J Nucl Med; 2012; 15(3):206-9. PubMed ID: 23106052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]